scholarly article | Q13442814 |
P356 | DOI | 10.1128/MCB.24.17.7514-7523.2004 |
P8608 | Fatcat ID | release_gcucv53ehrdvdaunt4n7orrywu |
P932 | PMC publication ID | 506993 |
P698 | PubMed publication ID | 15314161 |
P5875 | ResearchGate publication ID | 8397600 |
P2093 | author name string | Ana Aranda | |
Susana García-Silva | |||
P2860 | cites work | Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3 | Q22010472 |
The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain | Q24600925 | ||
An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cells | Q28142137 | ||
Thyroid hormone receptors/THR genes in human cancer | Q28187712 | ||
Physiological and molecular basis of thyroid hormone action | Q28203934 | ||
Nuclear hormone receptors and gene expression | Q28203943 | ||
Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase | Q28283499 | ||
The signal-dependent coactivator CBP is a nuclear target for pp90RSK | Q28286828 | ||
Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases | Q28298000 | ||
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein | Q28305440 | ||
ras oncogenes in human cancer: a review | Q29547769 | ||
Regulation of transcription by MAP kinase cascades | Q29618477 | ||
CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals | Q29620470 | ||
Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer | Q33682080 | ||
The v-erbA oncogene (review). | Q33736584 | ||
Fos family members induce cell cycle entry by activating cyclin D1. | Q33779543 | ||
pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v- | Q33854336 | ||
Specific protection against breast cancers by cyclin D1 ablation | Q34082446 | ||
Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones | Q34083450 | ||
Ras proteins in the control of the cell cycle and cell differentiation | Q34090530 | ||
AP-1--glucocorticoid receptor crosstalk taken to a higher level | Q34262748 | ||
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions | Q34295503 | ||
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. | Q34479232 | ||
Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma | Q34579987 | ||
The thyroid hormone receptor antagonizes CREB-mediated transcription | Q35107692 | ||
Overexpression of the beta 1 thyroid receptor induces differentiation in neuro-2a cells | Q35127027 | ||
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo | Q35207717 | ||
Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells | Q36552538 | ||
The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export | Q39455172 | ||
Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB. | Q39456448 | ||
8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein | Q39456804 | ||
Negative regulation of expression of the pituitary-specific transcription factor GHF-1/Pit-1 by thyroid hormones through interference with promoter enhancer elements | Q40017619 | ||
The mechanism of cell cycle regulation by v-Src. | Q40775817 | ||
Nuclear receptor/AP-1 interaction | Q40791352 | ||
Function and regulation of ras. | Q40835314 | ||
Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. | Q40855677 | ||
The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation | Q40973624 | ||
Induction of cyclin D1 overexpression by activated ras. | Q41415663 | ||
Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes | Q41654734 | ||
Inducible regulatory elements in the human cyclin D1 promoter | Q42498965 | ||
Multiple ras effector pathways contribute to G(1) cell cycle progression | Q42812883 | ||
Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-Src | Q42816578 | ||
Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma | Q43833469 | ||
Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer. | Q43945213 | ||
Transcriptional cross-talk, the second mode of steroid hormone receptor action | Q47862003 | ||
Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. | Q52548664 | ||
Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product | Q59098062 | ||
Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. | Q64979538 | ||
Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells | Q72992472 | ||
Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cells | Q73054399 | ||
Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27 | Q73959940 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7514-7523 | |
P577 | publication date | 2004-09-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation | |
P478 | volume | 24 |
Q40147190 | A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain. |
Q54189015 | Association between promoter methylation and expression of thyroid hormone receptor beta (THRβ) gene in patients with gastric cancer in an Iranian population. |
Q39415249 | Cell-type-dependent thyroid hormone effects on glioma tumor cell lines. |
Q92502907 | Deiodinases and their intricate role in thyroid hormone homeostasis |
Q34692085 | Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study. |
Q34914923 | Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis |
Q33775577 | Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma |
Q37831909 | Hedgehog-mediated regulation of thyroid hormone action through iodothyronine deiodinases |
Q33488530 | Hypothyroidism enhances tumor invasiveness and metastasis development |
Q28582121 | Involvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motility |
Q37643737 | Iodine mediated mechanisms and thyroid carcinoma |
Q46985015 | Iodothyronine deiodinases expression in thyroid neoplasias |
Q33819911 | Lessons from mouse models of thyroid cancer |
Q38766990 | Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β. |
Q35832908 | Modeling follicular thyroid cancer for future therapies |
Q35135691 | Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas |
Q36208333 | Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population |
Q58086853 | Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer |
Q35931083 | Nuclear receptor, coregulator signaling, and chromatin remodeling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis |
Q35781521 | Oncogenic mutations of thyroid hormone receptor β. |
Q37599892 | Role of type 3 deiodinase in cancer |
Q34654368 | Src-dependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activity |
Q26746255 | T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair |
Q58589490 | The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism |
Q37441332 | The thyroid hormone receptor β induces DNA damage and premature senescence. |
Q35085091 | The thyroid hormone receptors as modulators of skin proliferation and inflammation |
Q88639338 | Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling |
Q38766996 | Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer |
Q64260591 | Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies |
Q33631853 | Thyroid hormone increases bulk histones expression by enhancing translational efficiency |
Q40194625 | Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic |
Q37455473 | Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire |
Q35099103 | Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis |
Q36206509 | Thyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actions |
Q64460314 | Thyroid hormone receptor β1 domains responsible for the antagonism with the ras oncogene: role of corepressors |
Q42820152 | Thyroid hormone receptor-beta (TR beta 1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2. |
Q36238475 | Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma |
Q28752413 | Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs |
Q36158417 | Transcriptomal profiling of site-specific Ras signals |
Q34356150 | Unexpected maturation of PI3K and MAPK-ERK signaling in fetal ovine cardiomyocytes |